Recent 8-K filings for ABEO

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 11:30 UTC earnings item 2.02item 9.01

  Abeona Q1 net product revenue $8.7M; three ZEVASKYN patients treated; in-licenses PSMA T-cell therapy

source · ABEO on sec.gov